期刊文献+

连续切片联合免疫组化染色在临床Ⅰ、Ⅱ期乳腺癌前哨淋巴结隐性转移检测中的应用 被引量:5

Application of serial sections and immunohistochemical staining in detection of occult metastases in sentinel lymph node of stage I II breast cancer
暂未订购
导出
摘要 目的 探讨连续切片联合免疫组化染色在临床Ⅰ、Ⅱ期乳腺癌前哨淋巴结(SLN)隐性转移检测中的应用.方法 对43例临床Ⅰ、Ⅱ期乳腺癌患者行SLN亚甲蓝示踪法活检,行SLN活检和腋窝淋巴结清扫,对常规HE染色病理诊断阴性的SLN以100μm间距行连续切片后HE(SS HE)及CK19、SBEM、EpCAM免疫标记染色(SS HE+IHC),确定检测隐性转移的最佳间距及最佳免疫标记.结果 检出SLN者39例(72枚),每例患者1~4枚,平均1.8枚;检出非SLN 694枚,每例患者10~19枚,平均17.8枚.最大剖面HE染色阳性12例(27.9%),其中2例为微转移,CK19、SBEM、EpCAM阳性17例(39.5%);最大剖面HE阴性者通过SS HE检出隐性转移5例,其中微转移3例.SLN阴性的55枚淋巴结SS HE检出隐性转移5枚(9.0%),间距为100、200、300、400、500μm时SS HE+IHC隐性淋巴结转移的检出率分别为9.0%、7.3%、7.3%、3.6%、3.6%,间距200、300μm与400、500μm的差异有统计学意义(P<0.05).结论 应用连续切片结合免疫组化染色可以提高0.2~2mm的微转移检测率,从而提高临床分期准确率,对后期治疗具有重要的指导意义. Objective To evaluate the application of serial sections and immunohistochemical staining for breast sentinel lymph node (SLN) biopsy in detection of occult metastases of breast cancer. Methods Forty three patients with stage I , II breast cancer underwent SLN methylene blue tracer biopsy, outpost of the lymph node biopsy (of SLNB) and axillary lymph node dissection (of ALND). Negative SLN diagnosed by conventional HE staining were sliced with 100 μm space for serial sections, then HE(SS HE) and CK19, small breast epithelial mucin(SBEM), EpCAM immune labeling staining (SS+IHC) were applied to determine the optimal spacing for detecting occult metastases and the best immune markers. Results Thirty nine SLN cases were successfully detected in 43 patients with a success rate of 90.7%; among them 12 cases were positive in the largest section of HE staining of 72 SLN, including 2 cases of micrometastasis with a positive rate of 27.9%; the rates of 17 CK19, SBEM, EpCAM positive cases increased to 39.5%; 5 cases were detected to have occult metastases in the negative largest section of HE by the SS HE, including 3 cases of micrometastasis. The spacing were 100, 200, 300,400 and 500 tJ m in 55 negative conventional HE staining SLN, the rates of occult metastases detected by SS HE and IHC were 9.0%, 7.3%, 7.3%, 3.6% and 3.6%. There was no significant difference in the rates of occult metastases detection when comparing the spacing of 200,300 p m with the spacing of 100tJm (P 〉0.05), and when comparing to, the spacing of 400μm, 500μm there was significant difference (P〈0.05). Conclusion The application of serial section and IHC can increase the rate of 0.2-2mm micrometastasis detection and improve the accuracy of clinical staging and the guidance for post-treatment.
出处 《浙江医学》 CAS 2012年第12期986-989,共4页 Zhejiang Medical Journal
基金 浙江省医药卫生科研基金项目(2009A033)
关键词 乳腺癌 前哨淋巴结 微转移 乳腺小粘蛋白 Breast cancer Sentinel lymph node Micrometastasis SBEM
  • 相关文献

参考文献18

  • 1Langer I,Guller U,Berclaz G,et aI.Morbidity of sentinel lymph node biopsy (SLN) alone versus SLN and completion axillary lymph node dissection after breast cancer surgery:a prospective Swise multicenter study on 659 patients[J].Ann Surg,2007,245:452- 461.
  • 2Moriya T,Usami S,Tada H,et aI.Pathological evaluation of sentinel lymph nodes for breast cancer[J].Asian J Surg,2004,27:256-261.
  • 3Edge S B,Comptonn C C.The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM[J].Ann Surg Oncol,2010,17(6): 1471-1474.
  • 4Krag D,Weaver D,Asbikga T,et aI.The sentinel nold in breast cancer-a multicenter validation study [J].N Eng J Med,1998,339 (14):941-946.
  • 5刘晓丹,杜小华,黄文华,钟世镇.早期乳腺癌前哨淋巴结活检的假阴性分析[J].现代肿瘤医学,2009,17(9):1802-1804. 被引量:2
  • 6Nano M T, Kollias J,Farshid G,et aI.Clinical impact of false nega- tive sentinel biopsy in prinmry breast cancer[J].Br J Surg,2002, 89:1430-1434.
  • 7Noguchi M,AI-Shibi K I,Mohammed M,et al. Sentinel lymph nodes and breast carcinoma: analysis of 70 cases by frozen section[J].Ann Saudi Med,2005,25(2):111-114.
  • 8Turner R R,Chu K U,Qi K,et aI.Pathological features associated with nonsendnel lymph node meteastases in patients with metastais breast cancer in sentinel lymph node[J].Cancer,2000, 89:574-581.
  • 9王永胜,欧阳涛,王启堂,苏逢锡,朱时光,吴炅,尉承泽,王水,曹苏生,李济宇.中国前哨淋巴结活检多中心协作研究CBCSG-001最新资料报告[J].中华乳腺病杂志(电子版),2009,3(3):8-12. 被引量:58
  • 10Ganaraj A,Kuhn J A,Jones R C,et aI.Predjctor for nonsentinel node involvement in breast cancer patients with micromrtas- tases in the sentinel lymph node [J].Proc Bayl Univ Med Cent, 2003.16:3-6.

二级参考文献21

  • 1Van Rijk M, Nieweg OE, Rutgers E J, et al. Sentinel node biopsy before neoadjuvant chemotherapy spares breast cancer patients axillary lymph node dissection [ J ]. Ann Surg Oncol, 2006,475 - 479.
  • 2Giullano AE, Jones RC, Brennan M, et al. Sentinel lymphadenectomy in breast cancer [ J ]. Clin Oncol, 1997, 15 ( 6 ) : 2345 - 3350.
  • 3Aaron HC, John F, Arthur G J, et al. Prospective evaluation of clinical and pathologic detection of axillary metastases in patients with carcinoma of the breast [J]. Surgery, 1990,108 (4) :612 - 618.
  • 4Gregory MS, Frederick LM, Kevin D, et al. Total axillary lymph-adenectomy in the management of breast cancer [J]. Arch Surg, 1991,126:1336 - 1342.
  • 5Robert S, Boova MD, Roseann B, et al. Patterns of axillary nodal involvement in breast cancer : predictability of level one dissection [J].Ann Surg,1982,196 (6):642 -644.
  • 6Tuttle TM. Sentinel lymph node biopsy. Preferred met hod of axillary staging for breast cancer [ J ]. Minerva Ginecol, 2005,57 (3) :293 -303.
  • 7Zakaria S, Hoskin TL, Degnim AC. Safety and technical success of methylene blue dye for lymphatic mapping in breast cancer [ J ]. Ann J Surg,2008,196(2) :228 -233.
  • 8Harlow SP, Krag DN. Sentinel lymph node biopsy in breast cancer [ J ]. Breast Dis ,2001,12 ( 1 ) :43 - 55.
  • 9Lee JH, Ryu KW, Kim CG, et al. Sentinel node biopsy using dye and isotope double tracers in early gastric cancer[ J]. Ann Surg Oncol,2006,13 (9) : 1168 - 1174.
  • 10Luser. Optimal number of sentinel nodes after intradermal injection isotope and blue dye[J]. ANZ J Surg,2006,76(6) :472 -475.

共引文献58

同被引文献52

引证文献5

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部